Recent news on Striant

Columbia Laboratories Reports Preliminary Findings from the ...  -  Apr 26, 2007
PharmaLive.com (press release),The Company also markets STRIANT(R) (testosterone buccal system) for the treatment of hypogonadism in men. For more information, please visit

Columbia Laboratories Reports Preliminary Findings from the ...  -  26 Apr 2007
PharmaLive.com (press release),The Company also markets STRIANT(R) (testosterone buccal system) for the treatment of hypogonadism in men. For more information, please visit

Columbia Laboratories Reports Fourth Quarter and Year-End 2006 ...  -  Mar 15, 2007
PharmaLive.com (press release),Sales of STRIANT during the year were limited to reduce inventory levels at our major distributors. STRIANT sales will be driven by real-time prescription

Columbia Laboratories to Discuss Infertility Business Outlook and ...  -  Feb 26, 2007
PharmaLive.com (press release),PROCHIEVE 4% (progesterone gel), and STRIANT(R) (testosterone buccal tablet) in the US; the timely and successful completion of clinical studies;

The Investment Column: Highland Gold worth holding despite two ...  -  Feb 13, 2007
Independent,Ardana yesterday unveiled a deal granting exclusive rights for the marketing of its Striant SR product in Holland. The news is significant for the

Wednesday tips round-up: Bradford & Bingley, British Land, Pure Wafer  -  Feb 13, 2007
ShareCast,Ardana yesterday unveiled a deal granting exclusive rights for the marketing of its Striant SR product in Holland, a deal that should also help build up its

Phase III Trial of Progesterone for the Prevention of Preterm ...  -  Feb 5, 2007
PharmaLive.com (press release),The Company also markets STRIANT(R) (testosterone buccal system) for the treatment of hypogonadism in men. For more information, please visit

Ardana goes Dutch with hormone pill  -  Feb 14, 2007
Scotsman,ARDANA, the Edinburgh biotech company, said it had struck an exclusive deal with Dutch firm TwinPharma to market its Striant testosterone replacement

UPDATE 1-Columbia Labs shares crash as gel trial fails  -  Feb 5, 2007
ReutersColumbia also markets Crinone, a progesterone gel, and Striant, a delivery system for testosterone replacement therapy in men.

Roth 2007 OC Conference Presenter Profiles  -  Feb 16, 2007
American Digital Networks (press release),The Company also markets STRIANT(R) (testosterone buccal system) for the treatment of hypogonadism in men. The Company recently completed enrollment in a

Columbia Laboratories Closes $40 Million Private Placement of ...  -  18 Jan 2007
Genetic Engineering News (press release),The Company also markets STRIANT(R) (testosterone buccal system) for the treatment of hypogonadism in men. The Company recently completed the treatment

Columbia Laboratories to Raise $40 Million Through Private ...  -  18 Jan 2007
Business Wire (press release),The Company also markets STRIANT ® (testosterone buccal system) for the treatment of hypogonadism in men. The Company recently completed enrollment in a

Ardana targets US firms for takeover  -  Dec 19, 2006
The Herald,The company has three drugs on the market – Emselex, Invicorp and Striant, its testosterone replacement therapy. Shares in the company yesterday dipped 0.4%

Columbia Laboratories Closes $40 Million Private Placement of ...  -  26 Dec 2006
Genetic Engineering News (press release),The Company also markets STRIANT(R) (testosterone buccal system) for the treatment of hypogonadism in men. The Company recently completed the treatment

James Meer Appointed Chief Financial Officer of Columbia Laboratories  -  Dec 8, 2006
PharmaLive.com (press release),The Company also markets STRIANT(r) (testosterone buccal system) for the treatment of hypogonadism in men. The Company recently completed enrollment in a

Ardana targets US firms for takeover  -  Dec 19, 2006
The Herald,The company has three drugs on the market – Emselex, Invicorp and Striant, its testosterone replacement therapy. Shares in the company yesterday dipped 0.4%

Ardana interim losses widen UPDATE  -  Dec 19, 2006
Hemscott,Ardana now has three drugs launched in various markets in Europe -- Emselex, an injectable treatment for erectile dysfunction called Invicorp and Striant SR

Ardana interim losses widen UPDATE  -  Dec 19, 2006
Hemscott,Ardana now has three drugs on the market, Emselex, Invicorp and Striant SR, a testosterone replacement therapy. The group also announced today the launch of

Columbia Laboratories Reports Third Quarter 2006 Financial Results  09 Nov 2006
...in the third quarter of 2005, driven by an increase in the sales of the PROCHIEVE line of products offset by a decrease in STRIANT ® (testosterone buccal ... -Business Wire (press release), Columbia Laboratories to Present at Rodman & Renshaw Healthcare ...  Oct 26, 2006
...secondary amenorrhea. The Company also markets STRIANT ® (testosterone buccal system) for the treatment of hypogonadism in men. The ... -Business Wire (press release), Columbia Laboratories Comments on FDA Reproductive Drugs Advisory ...  Aug 30, 2006
...secondary amenorrhea. The Company also markets STRIANT(R) (testosterone buccal system) for the treatment of hypogonadism in men. The ... -PharmaLive.com

ROTH New York Conference 2006 Presenter Profiles  Sep 1, 2006
...secondary amenorrhea. The Company also markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men. The ... -Business Wire

James Meer Appointed Chief Financial Officer of Columbia Laboratories  -  Dec 8, 2006
PharmaLive.com (press release),The Company also markets STRIANT(r) (testosterone buccal system) for the treatment of hypogonadism in men. The Company recently completed enrollment in a

Columbia Laboratories Completes Enrollment in Pivotal Phase III ...  Aug 1, 2006
...amenorrhea. The Company also markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men. Columbia's ... -PharmaLive.com

Columbia Laboratories to Present at Roth Capital Partners Equity ...  Aug 7, 2006
...secondary amenorrhea. The Company also markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men. The ... -PharmaLive.com

Columbia Laboratories Reports Second Quarter 2006 Financial ...  Aug 9, 2006
...$1.1 million in the second quarter of 2006, compared to $1.7 million in the second quarter of 2005, primarily as a result of lower sales of Striant and the ... -Business Wire

Upbeat Ardana's losses are developing  Jun 29, 2006
Sales more than tripled to £490,000 after the company rolled out its first product, Striant, another therapy for hypogonadism. ... -Scotsman

Healthy progress for Ardana despite losses hitting £8.8m  Jun 30, 2006
...the development stage of its products, saw revenues climb to £490,000 from £135,000 on the back of the launch of its first product, Striant, a testosterone ... -Scotsman

Ardana stands up to the challenge despite losses  Jun 29, 2006
Revenues climbed to £490,000 from £135,000, after the Edinburgh-based pharmaceutical developer introduced its first product, Striant, an oral treatment for ... -The Herald

Ardana says FY losses largely unchanged  Jun 29, 2006
Revenues climbed to 490,000 stg from 135,000, after the company launched its first product, Striant, a testosterone replacement therapy. ... -Life Style Extra

City diary  Jun 28, 2006
...previously. Sales were up to £164,000 from £22,000, helped by the launch of its key testosterone replacement drug Striant. Brokers ... -Edinburgh Evening News



Columbia Laboratories Added to NASDAQ Biotechnology Index  May 15, 2006
...amenorrhea. The Company also markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men. Columbia's ... - PharmaLive.com





Ardana appoints Klaus Falk as VP Sales & Marketing  Mar 17, 2006
With Striant on the market; a planned launch for Invicorp later this year, and various in-licensing opportunities, we are delighted that Klaus will be leading ... - PharmaLive.com

Ardana brings in sales heavyweight with eye on second launch  Mar 17, 2006
The company has already launched Striant, its testosterone replacement treatment for men with hypergonadism, and is planning to launch Invicorp, an injection ... - Scotsman



Columbia Laboratories Announces Management Changes  Jan 9, 2006
...amenorrhea. The Company also markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men. Columbia's ... - PharmaLive.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional